[Vasoconstrictive activity of a new anti-inflammatory agent in man: difluprednate].
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001624:Betamethasone Valerate / Q000494:pharmacology; D003907:Dexamethasone / Q000031:analogs & derivatives / Q000494:pharmacology; D005260:Female; D005446:Fluocinolone Acetonide / Q000031:analogs & derivatives / Q000494:pharmacology; D005477:Fluprednisolone / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D008297:Male; D008875:Middle Aged; D014222:Triamcinolone Acetonide / Q000494:pharmacology; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D014662:Vasoconstrictor Agents; D005446:Fluocinolone Acetonide; D003907:Dexamethasone; D005477:Fluprednisolone; D001624:Betamethasone Valerate; D014222:Triamcinolone Acetonide; C015808:difluprednate
Activité vasoconstrictrice chez l'homme d'un nouvel anti-inflammatoire: le difluprednate.